Observational studyFrontiers in endocrinology2024

GH receptor polymorphisms guide second-line therapies to prevent acromegaly skeletal fragility: preliminary results of a pilot study.

Sabrina Chiloiro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.